TotalMarketCap

Cellectis

CLLSNasdaq FranceHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$101.533 M

$1.01 -13.68%

Close of 6 Nov 2026

As of 6 Nov 2026, Cellectis (CLLS) has a market capitalization of $101.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #289EquilliumEQ$103.8M
  2. #290OnKure TherapeuticsOKUR$102.3M
  3. #291CellectisCLLS$101.5M
  4. #292ImmunicIMUX$101.0M
  5. #293NRX PharmaceuticalsNRXP$98.2M

What if Cellectis were worth as much as…

Open the what-if tool →

Gold $28.2T

$280,887.68

Per share 278,107× higher

Bitcoin $1.53T

$15,198.34

Per share 15,048× higher

Apple $5.02T

$49,894.74

Per share 49,401× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Cellectis are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.